SCHEMBL6694919

SCHEMBL6694919

O=C(NCc1ccccc1F)c1ccc2c(c1)ncn2-c1n[nH]c2ccccc12

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TP53 P04637 5/20 0.53
LMNA P02545 1/20 0.48
EPHX2 P34913 2/20 0.44
PPARG P37231 2/20 0.44
ROCK2 O75116 2/20 0.44
TDP1 Q9NUW8 1/20 0.44
HPGD P15428 5/20 0.43
MAPK1 P28482 3/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
MAPK3 P27361 1/20 0.42
ALDH1A1 P00352 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6702873 0.91 TP53 (0.47) TP53LMNAEPHX2PPARGTDP1
SCHEMBL6664832 0.89 TP53 (0.54) TP53LMNATDP1HPGDMAPK1
SCHEMBL6703136 0.89 TP53 (0.47) TP53LMNAEPHX2PPARGTDP1
SCHEMBL6702887 0.88 MAPK1 (0.49) TP53LMNAPPARGTDP1HPGD
SCHEMBL6694288 0.88 TP53 (0.51) TP53TDP1HPGDMAPK1NPC1
SCHEMBL6703840 0.85 TP53 (0.53) TP53LMNAEPHX2PPARGTDP1
SCHEMBL6705339 0.85 TP53 (0.44) TP53LMNAROCK2TDP1HPGD
SCHEMBL6699272 0.84 TP53 (0.51) TP53LMNAPPARGTDP1MAPK1
SCHEMBL6664702 0.83 TP53 (0.54) TP53LMNAPPARGTDP1HPGD
SCHEMBL6700631 0.80 ALDH1A1 (0.46) TP53LMNAPPARGROCK2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1441725-A1 BENZIMIDAZOLES AND ANALOGUES AND THEIR USE AS PROTEIN KINASES INHIBITORS Aventis Pharmaceuticals Inc. (US) 2004-08-04 EP claimed
WO-2003035065-A1 BENZIMIDAZOLES AND ANALOGUES AND THEIR USE AS PROTEIN KINASES INHIBITORS AVENTIS PHARMACEUTICALS INC (US) 2003-05-01 WO claimed